York, Pa. – September 24, 2026 – Supira Medical recently announced on LinkedIn that WellSpan Health has joined the SUPPORT II pivotal trial, becoming the first health system in Pennsylvania to evaluate the investigational Supira System during complex cardiac procedures.

LinkedIn post announcing WellSpan Health as the first in Pennsylvania to join the SUPPORT II trial with Supira Medical.